Rare diseases
Investigational molecules
Locations
Back to Bulgaria43 clinical trials in Montana, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
BulgariaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
BulgariaStudy on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen
BulgariaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
BulgariaStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
BulgariaA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
BulgariaA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
BulgariaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
BulgariaA study of IM-101 in adults with generalized myasthenia gravis or ocular myasthenia gravis
BulgariaStudy of oral cladribine compared to placebo for patients with generalized myasthenia gravis
BulgariaA Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on respiratory conditions, including studies of new treatments for COPD, severe asthma, and bronchiectasis. Research evaluates both established and novel therapeutic approaches.
Multiple trials testing triple therapy combinations and novel compounds for improved patient outcomes.
Comprehensive research into cardiovascular diseases, with trials examining new treatments for atherosclerosis and stroke prevention. Studies focus on reducing major adverse cardiovascular events.
Innovative therapies targeting lipid management and vascular health improvement.
Advanced research on viral infections and preventive measures, including studies of novel vaccines and antiviral treatments. Particular focus on respiratory viruses and their complications.
Evaluation of both therapeutic and preventive interventions for viral diseases.
Specialized trials investigating treatments for chronic kidney disease and related conditions. Research includes both medication efficacy and patient care improvements.
Focus on improving outcomes for patients with kidney-related conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
